| Literature DB >> 24803309 |
Ferid Krupic1, Göran Garellick, Max Gordon, Johan Kärrholm.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2014 PMID: 24803309 PMCID: PMC4062786 DOI: 10.3109/17453674.2014.919556
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Patient data
| Variables | Born in Sweden n (%) | Nordic Countries | Europe | Outside Europe |
|---|---|---|---|---|
| Sex | ||||
| Male | 7,407 (43) | 254 (31) | 222 (42) | 61 (56) |
| Female | 9,933 (57) | 565 (69) | 301 (58) | 48 (44) |
| Age, mean | 68.5 | 68.0 | 66.7 | 61.3 |
| (95% CI) | (68.4–68.6) | (67.4–68.6) | (65.8–67.7) | (58.4–64.3) |
| < 60 years | 3,159 (18) | 151 (18) | 124 (24) | 52 (48) |
| ≥ 60 years | 14,181 (82) | 668 (82) | 399 (76) | 57 (52) |
| Diagnoses | ||||
| Primary OA | 15,756 (91) | 743 (91) | 475 (91) | 84 (77) |
| Secondary OA | 1,584 (9) | 76 (9) | 48 (9) | 25 (23) |
| Charnley class | ||||
| A + B | 9,638 8 (56) | 417 (51) | 245 (47) | 44 (40) |
| C | 7,701 (44) | 402 (49) | 278 (53) | 65 (60) |
| Cohabiting | ||||
| Yes | 10,746 (62) | 476 (58) | 304 (58) | 73 (67) |
| No | 6,594 (38) | 343 (42) | 219 (42) | 36 (33) |
| Education (ISCED 97) | ||||
| Low | 10,123 (58) | 505 (62) | 231 (44) | 54 (49) |
| Middle/High | 7,217 (42) | 314 (38) | 292 (56) | 55 (51) |
| Comorbidity score | ||||
| Elixhauser 0 | 11,731 (68) | 539 (66) | 337 (64) | 72 (66) |
| Elixhauser ≥ 1 | 5,609 (32) | 280 (34) | 186 (36) | 37 (34) |
| Charlson 0 | 14,386 (83) | 656 (80) | 417 (80) | 83 (76) |
| Charlson ≥ 1 | 2,954 (17) | 163 (20) | 106 (20) | 26 (24) |
| Type of fixation | ||||
| Cemented | 14,429 (83) | 681 (83) | 402 (77) | 59 (54) |
| Uncemented, hybrid, | ||||
| reversed hybrid | 2,911 (17) | 138 (17) | 121 (23) | 50 (46) |
| Incision | ||||
| Lateral | 5,929 (34) | 356 (43) | 234 (45) | 60 (55) |
| Posterior | 11,411 (66) | 463 (57) | 289 (55) | 49 (45) |
Excluding Sweden.
Excluding previous Soviet Union.
Including previous Soviet Union.
Mean, 95% confidence interval of the mean.
No comorbidity (0) or 1 or more comorbidities according to Elixhauser or Charlson.
Figure 1.Odds ratio for reporting of moderate or severe preoperative problems in 4 of the 5 EQ5D domains. Unadjusted data (top) and adjusted data (bottom) are presented. Pain/discomfort was not analyzed because of poor variability. The risk ratios and their 95% confidence intervals are shown. Bars indicate p-values.
VAS for pain and EQ-5D values preoperatively and after 1 year, and VAS for patient satisfaction after 1 year for patients born in and outside Sweden
| Preoperatively | 1 year postoperatively | |||
|---|---|---|---|---|
| Mean (95%CI) | p-value | Mean (95%CI) | p-value | |
| Pain VAS | ||||
| Sweden | 61 (60–61) | < 0.001 | 14 (13–14) | < 0.001 |
| Nordic Countries | 63 (62–64) | 0.003 | 17 (16–18) | < 0.001 |
| Europe | 63 (61–64) | 0.05 | 19 (18–21) | < 0.001 |
| Outside Europe | 66 (63–69) | 0.001 | 23 (19–26) | < 0.001 |
| Satisfaction VAS | ||||
| Sweden | – | – | 16 (16–17) | < 0.001 |
| Nordic countries | – | – | 19 (17–20) | 0.008b |
| Europe | – | – | 20 (18–22) | < 0.001 |
| Outside Europe | – | – | 24 (20–28) | < 0.001 |
| EQ-VAS | ||||
| Sweden | 53 (52–53) | 0.002 | 75 (75–76) | < 0.001 |
| Nordic countries | 50 (48–52) | < 0.001 | 73 (71–74) | 0.002 |
| Europe | 52 (49–54) | 0.2 | 69 (67–71) | < 0.001 |
| Outside Europe | 53 (48–58) | 0.9 | 69 (64–73) | 0.002 |
| EQ-5D | ||||
| Sweden | 0.40 (0.39–0.41) | < 0.001 | 0.78 (0.77–0.78) | < 0.001 |
| Nordic countries | 0.36 (0.34–0.38) | < 0.001 | 0.74 (0.72–0.76) | < 0.001 |
| Europe | 0.33 (0.30–0.36) | < 0.001 | 0.70 (0.67–0.72) | < 0.001 |
| Outside Europe | 0.29 (0.23–0.36) | < 0.001 | 0.64 (0.58–0.70) | < 0.001 |
All groups (ANOVA).
Born in Sweden vs. immigrant groups (Student’s t-test).
Figure 2.Odds ratio for reporting of moderate or severe problems 1 year after operation in the 5 EQ5D domains. Unadjusted data (top) and adjusted data (bottom) are presented. The risk ratios and their 95% confidence intervals are shown. Bars indicate p-values.